Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
IPT-002 mRNA Booster
- Development stage
- Preclinical
- Lead developer
- Hervolution Therapeutics
- Modality
- mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
IPT-002 mRNA Booster is a preclinical-stage mRNA-based immunotherapy being developed by Hervolution Therapeutics. It is designed to target the Human Endogenous Retrovirus-K (HERV-K) antigen, which is often aberrantly expressed in various cancers and certain metabolic conditions. The drug utilizes an mRNA vector to stimulate a robust immune response against HERV-K-expressing cells. It is specifically intended to support repeat dosing or function as part of a prime-boost strategy in conjunction with Hervolution's lead candidate, IPT-001. The program is currently in lead optimization for the treatment of solid tumors and undisclosed metabolic diseases.
- Other names
- IPT-002 mRNA BoosterIPT002 mRNA BoosterIPT 002 mRNA Booster
02
Targets
Human endogenous retrovirus K envelope protein
Beyond the preview
Go deeper on IPT-002 mRNA Booster.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on IPT-002 mRNA Booster.